Association of Urinary Interferon Gamma Protein-10 Levels and Low Levels of Cluster of Differentiation 4 Serum in Patients with Tuberculosis-Human Immunodeficiency Virus Coinfection

Dwitya Elvira

doi:10.3889/oamjms.2021.6661

Authors

Dwitya Elvira Department of Internal Medicine, Allergy Immunology Subdivision, Faculty of Medicine, Universitas Andalas, Padang, Indonesia https://orcid.org/0000-0003-0227-7735

DOI:

https://doi.org/10.3889/oamjms.2021.6661

Keywords:

CD4 serum, chemokines, HIV/AIDS, IP-10 Urine, TB/HIV Co-infection

Abstract

BACKGROUND: Tuberculosis (TB) infection caused by Mycobacterium tuberculosis was the most frequent opportunistic infection in human immunodeficiency virus (HIV) patients that lead to increasing of morbidity and mortality. Very low cluster of differentiation 4 (CD4) levels causing problem in TB/HIV diagnostic because unspecific clinical manifestation. Urine interferon gamma protein-10 (IP10) examination is a method that is relatively easier and safer to do, so it can be used as an alternative method in establishing the diagnosis TB/HIV.

AIM: The aim of this study was to investigate the association between urinary IP-10 and level of CD4 serum in patients with TB/HIV coinfection.

MATERIALS AND METHODS: This study was conducted at the Department of Internal Medicine, Faculty of Medicine, Dr. M. Djamil Hospital, Padang, Indonesia, involved 30 patients with active TB/HIV coinfection whose urine and blood serum were collected to evaluate IP-10 and CD4 level.

RESULTS: There is a significant relationship between urine IP10 levels as a biomarker for the diagnosis of active pulmonary TB in HIV patients and serum CD4 levels in TB-HIV coinfected patients with moderate correlation strength.

CONCLUSION: Further research is needed with a larger sample size to see the effect of low serum CD4 levels on the sensitivity of urine IP10 diagnosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Murray C, Ortoblad K, Guinovart C, Lim S, Wolock T, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9947):1005-70. PMid:25059949

Gopalan N, Chandrasekaran P, Swaminathan S, Tripathy S. Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis. AIDS Res Ther. 2016;13(34):1-19. https://doi.org/10.1186/s12981-016-0118-7 PMid:27708678 DOI: https://doi.org/10.1186/s12981-016-0118-7

Suthar A, Lawn S, Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis adults with HIV: A systematic review and meta-analysis. PLoS Med. 2012;9(7):1-15. https://doi.org/10.1371/journal.pmed.1001270 PMid:22911011 DOI: https://doi.org/10.1371/journal.pmed.1001270

World Health Organization. Global Tuberculosis Report. Geneva: World Health Organization; 2012.

Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. Urine for the diagnosis of tuberculosis: Current approaches, clinical applicability and new developments. Curr Opin Pulm Med. 2010;16(3):262-70. https://doi.org/10.1097/mcp.0b013e328337f23a PMid:20375787 DOI: https://doi.org/10.1097/MCP.0b013e328337f23a

Lei J, Yin X, Shang H, Jiang Y. IP-10 is highly involved in HIV infection. Cytokine. 2019;115:97-103. https://doi.org/10.1016/j.cyto.2018.11.018 PMid:30472104 DOI: https://doi.org/10.1016/j.cyto.2018.11.018

Hong JY, Lee HJ, Kim SY, Chung KS, Kim EY, Jung JY, et al. Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment. J Infect. 2014;68(3):252-8. PMid:24247066 DOI: https://doi.org/10.1016/j.jinf.2013.09.033

Direktorat Jenderal Pengendalian Penyakit Menular dan Penyehatan Lingkungan Kementerian Kesehatan Republik Indonesia. Indonesia: Laporan Statistik Kasus HIV-AIDS Indonesia; 2014.

Petrone L, Cannas A, Aloi F, Nsubuga M, Sserumkuma J, Nazziwa RA, et al. Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children. BioMed Res Int. 2015;2015:589471. https://doi.org/10.1155/2015/589471 PMid:26346028 DOI: https://doi.org/10.1155/2015/589471

Petrone L, Cannas A, Vanini V, Cuzzi G, Aloi F, Nsubuga M, et al. Blood and urine IP-10 as potential marker of disease activity. Int J Tuberc Lung Dis. 2016;20(11):1554-61. https://doi.org/10.5588/ijtld.16.0342 PMid:27776600 DOI: https://doi.org/10.5588/ijtld.16.0342

Cahyadi E. Association Between Clinical Stage and CD4 Level in HIV Patients in Banda Aceh Hospital. Geneva, Switzerland: ICRC; 2014. p. 1-5.

Directorate General of Infectious Disease Control and Environmental Health of the Ministry of Health Republic of Indonesia. Indonesia: Technical Guidelines Management of TB/HIV Co-infection; 2012.

Cannas A, Calvo L, Chiacchio T, Cuzzi G, Vanini V, Lauria FN, et al. IP-10 detection in urine is associated with lung diseases. BMC Infect Dis. 2010;10(333):1-8. https://doi.org/10.1186/1471-2334-10-333 PMid:21092156 DOI: https://doi.org/10.1186/1471-2334-10-333

Latorre I, Diaz J, Mialdea I, Serra-Vidal M, Altet N, Prat C, et al. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children. J Infect. 2014;69(6):590-9. https://doi.org/10.1016/j.jinf.2014.06.013 PMid:24975172 DOI: https://doi.org/10.1016/j.jinf.2014.06.013

Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, et al. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. J Infect. 2015;70(4):381-91. https://doi.org/10.1016/j.jinf.2014.12.019 PMid:25597826 DOI: https://doi.org/10.1016/j.jinf.2014.12.019

Contreas G, Donnachie E, Murphy JR, Heresy GP. Elevated IP10 associates with CD8 cell activation and low CD4 in perinatally acquired HIV infection. OFID. 2014;1(1):S427. https://doi.org/10.1093/ofid/ofu052.1164 DOI: https://doi.org/10.1093/ofid/ofu052.1164